3-(Imidazolyl)-2-aminopropanoic acids
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 6, 2004
Grant Date -
Oct 9, 2003
app pub date -
Jan 22, 2003
filing date -
Jan 22, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds according to formula (I) wherein n is 1-4, R.sup.1 is optionally substituted C.sub.1-6 alkyl, C.sub.2-6 alkenyl, or C.sub.2-6 alkynyl, Heterocycle, Aromatic heterocycle, Aryl or hydrogen and R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are each independently selected from hydrogen and optionally substituted C.sub.1-6 alkyl are novel. They are useful in the treatment of thrombotic conditions and other pathologies associated with fibrin deposition. ##STR1##
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully